Evaluation of a truncated recombinant flagellin subunit vaccine against Campyiobacter jejuni

Lanfong H. Lee, Edward Burg, Shahida Baqar, A. L. Bourgeois, Don H. Burr, Cheryl P. Ewing, Trevor J. Trust, Patricia Guerry

Research output: Contribution to journalArticlepeer-review

75 Scopus citations


A recombinant protein comprising the maltose-binding protein (MBP) of Escherichia coli fused to amino acids 5 to 337 of the FlaA flagellin of Campylobacter coli VC167 was evaluated for immunogenicity and protective efficacy against challenge by a heterologous strain of campylobacter, Campylobacter jejuni 81-176, in two murine models. The sequence of the flaA gene of strain 81-176 revealed a predicted protein which was 98.1% similar to that of VC167 FlaA over the region expressed in the fusion protein. Mice were immunized intranasally with two doses of 3 to 50 μg of MBP-FlaA, given 8 days apart, with or without 5 μg of the mutant E. coli heat-labile enterotoxin (LT(R192G)) as a mucosal adjuvant. The full range of MBP-FlaA doses were effective in eliciting antigen-specific serum immunoglobulin G (IgG) responses, and these responses were enhanced by adjuvant use, except in the highest dosing group. Stimulation of FiaA-specific intestinal secretory IgA (sIgA) responses required immunization with higher doses of MBP-FlaA (≥25 χ) or coadministration of lower doses with the adjuvant. When vaccinated mice were challenged intranasally 26 days after immunization, the best protection was seen in animals given 50 μg of MBP-FlaA plus LT(R192G). The protective efficacies of this dose against disease symptoms and intestinal colonization were 81.1 and 84%, respectively. When mice which had been immunized with 50 μg of MBP-FlaA plus LT(R192G) intranasally were challenged orally with 8 x 1010, 8 x 109, or 8 x 108 cells of strain 81- 176, the protective efficacies against intestinal colonization at 7 days postinfection were 71.4, 71.4, and 100%, respectively.

Original languageEnglish (US)
Pages (from-to)5799-5805
Number of pages7
JournalInfection and immunity
Issue number11
StatePublished - Nov 1999
Externally publishedYes

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'Evaluation of a truncated recombinant flagellin subunit vaccine against Campyiobacter jejuni'. Together they form a unique fingerprint.

Cite this